#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA615600	F	Effective dose against murine 3T3 fibroblasts cells	Mus musculus	40		cell-based format	Scientific Literature
2.	ALA751314	F	Inhibition of Ha-Ras processing in NIH3T3 Ras transformed cells.	Homo sapiens	4		cell-based format	Scientific Literature
3.	ALA769088	B	Inhibition of Trypanosoma brucei protein farnesyltransferase	Trypanosoma brucei brucei	5		protein complex format	Scientific Literature
4.	ALA817909	F	Effective dose required to inhibit the growth of Trypanosoma brucei	Trypanosoma brucei brucei	31		organism-based format	Scientific Literature
5.	ALA818012	F	Effective dose required to inhibit the growth of Trypanosoma brucei rhodesiense	Trypanosoma brucei rhodesiense	26		organism-based format	Scientific Literature
6.	ALA1614174	F	PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory)	Bacillus subtilis	24,076		assay format	PubChem BioAssays
7.	ALA1614249	B	PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)]	Equus caballus	42,059		single protein format	PubChem BioAssays
8.	ALA1614364	B	PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1). (Class of assay: confirmatory)	Homo sapiens	11,958		single protein format	PubChem BioAssays
9.	ALA1794311	F	PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855]		20,122		assay format	PubChem BioAssays
10.	ALA2363475	F	SANGER: Inhibition of human NCI-H1563 cell growth in a cell viability assay.	Homo sapiens	98		cell-based format	Sanger Institute Genomics of Drug Sensitivity in Cancer
11.	ALA2363477	F	SANGER: Inhibition of human NCI-H1581 cell growth in a cell viability assay.	Homo sapiens	137		cell-based format	Sanger Institute Genomics of Drug Sensitivity in Cancer
12.	ALA2363478	F	SANGER: Inhibition of human NCI-H1618 cell growth in a cell viability assay.	Homo sapiens	38		cell-based format	Sanger Institute Genomics of Drug Sensitivity in Cancer
13.	ALA2363479	F	SANGER: Inhibition of human NCI-H1623 cell growth in a cell viability assay.	Homo sapiens	98		cell-based format	Sanger Institute Genomics of Drug Sensitivity in Cancer
14.	ALA2363480	F	SANGER: Inhibition of human NCI-H1648 cell growth in a cell viability assay.	Homo sapiens	133		cell-based format	Sanger Institute Genomics of Drug Sensitivity in Cancer
15.	ALA2363481	F	SANGER: Inhibition of human NCI-H1650 cell growth in a cell viability assay.	Homo sapiens	134		cell-based format	Sanger Institute Genomics of Drug Sensitivity in Cancer
16.	ALA2363482	F	SANGER: Inhibition of human NCI-H1651 cell growth in a cell viability assay.	Homo sapiens	98		cell-based format	Sanger Institute Genomics of Drug Sensitivity in Cancer
17.	ALA2363484	F	SANGER: Inhibition of human NCI-H1693 cell growth in a cell viability assay.	Homo sapiens	98		cell-based format	Sanger Institute Genomics of Drug Sensitivity in Cancer
18.	ALA2363485	F	SANGER: Inhibition of human NCI-H1694 cell growth in a cell viability assay.	Homo sapiens	77		cell-based format	Sanger Institute Genomics of Drug Sensitivity in Cancer
19.	ALA2363486	F	SANGER: Inhibition of human NCI-H1703 cell growth in a cell viability assay.	Homo sapiens	81		cell-based format	Sanger Institute Genomics of Drug Sensitivity in Cancer
20.	ALA2363487	F	SANGER: Inhibition of human NCI-H1734 cell growth in a cell viability assay.	Homo sapiens	38		cell-based format	Sanger Institute Genomics of Drug Sensitivity in Cancer